Table 2 The clinicopathological risk factors in patients with locally advanced cervical cancer
Variables | NACT, N (%) | PRS, N (%) | P-value (χ2 test) |
|---|---|---|---|
Total | 197 | 217 | Â |
Preoperative tumor size | Â | Â | < 0.001 |
 ≤ 2.0 cm | 71 (36.0) | 43 (19.8) |  |
 2.1~4.0 cm | 78 (39.6) | 126 (58.1) |  |
 > 4.0 cm | 48 (24.4) | 48 (22.1) |  |
Parametrial involvement | Â | Â | 0.776 |
 Negative | 169 (85.8) | 184 (84.8) |  |
 Positive | 28 (14.2) | 33 (15.2) |  |
Lymph node metastasis | Â | Â | 0.336 |
 Negative | 134 (68.0) | 157 (72.4) |  |
 Positive | 63 (32.0) | 60 (27.6) |  |
LVSI | Â | Â | 0.135 |
 Negative | 150 (76.1) | 151 (69.6) |  |
 Positive | 47 (23.9) | 66 (30.4) |  |
Cervical stromal invasion | Â | Â | 0.023 |
 < 1/3 | 40 (20.3) | 36 (16.6) |  |
 1/3~2/3 | 20 (10.2) | 41 (18.9) |  |
 ≥ 2/3 | 72 (36.5) | 88 (40.6) |  |
 Unknown | 65 (33.0) | 52 (24.0) |  |
Surgery margin | Â | Â | 0.128 |
 Negative | 190 (96.4) | 202 (93.1) |  |
 Positive | 7 (3.6) | 15 (6.9) |  |